Spanish Red Biotech Pipeline

IRYCIS

New biomarkers to identify good responders to cis-platinum in lug cancer

Type: Biomarkers / Diagnostic
Therapeutic area: Cancer
Indication: New biomarkers based on aptamers technology (target MAFG) to identify good responders to cis-platinum in lug cancer
Phase: 2Preclinical Validation, 1R+D
Studies location: